New leadership will drive OGT’s mission to improve clinical care by partnering with customers Oxford, UK – OGT, A Sysmex Group Company, announces the appointment of Adrian Smith as CEO from 1st April 2022. The appointment comes as Dr John Anson retires from his position as CEO and member of the Board, after more than 16 years […]
LGC has today announced the acquisition of Rapid Genomics, a provider of mid- to high-density Next-Generation Sequencing (NGS) kits and services for genotyping in the agrigenomics market. Rapid Genomics is a leading company in genotyping applications via Next-Generation Sequencing (NGS). Its Flex-Seq® Ex-L technology is provided to customers through kits and genotyping services, and allows high-throughput, […]
AddLife is continuing its expansion in Europe by acquiring BioCat GmbH (“BioCat”), for inclusion in its Labtech business area. BioCat is a specialized distributor of products and services to the life science research market with annual revenues of EUR 9m. The company is located in Germany but also has sales in Austria and Switzerland, giving […]
BD Rhapsody™ TCR/BCR Multiomic Assay speeds discovery in autoimmune disorders, immuno-oncology and infectious diseases FRANKLIN LAKES, N.J. – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, recently released the BD Rhapsody™ TCR/BCR Multiomic Assay, an innovative set of reagents that enables researchers to more easily and comprehensively analyze important cells in […]
Clive G Brown, CTO, Oxford Nanopore Technologies, reviews some of the latest technology updates during a webinar today. Highlights include performance and base modification calling improvements, as well as updates on the recently-released Short Fragment Mode (SFM) and a new basecaller. Summary: Latest chemistry enables 99.3% raw read accuracy at high data yields; new Kit […]
MADISON, Wis. — Life science researchers can explore new ideas for genome engineering technology through a newly announced post-doctoral research program launched by Promega with mentoring support from AstraZeneca. The program gives researchers the unique opportunity to work on groundbreaking projects in an emerging field while collaborating with scientists at a global pharmaceutical company and […]
Caligan Partners to Vote “FOR” Casdin and Viking Transaction and All Other Fluidigm Proposals at the Special Meeting to be Reconvened on April 1, 2022 Fluidigm Board to Appoint Frank Witney, a Director Candidate Recommended by Caligan, if Casdin and Viking Transaction Closes Company Urges ALL Stockholders to Vote “FOR” the Proposals at the Special Meeting SOUTH SAN […]
MGI is pleased that the Court in the Northern District of California denied Illumina’s request to overturn the jury’s decision invalidating the ‘444 patent. The 444 patent was not set to expire until June 2023. Because the other patents Illumina asserted against MGI’s CoolMPSTM technology expire in August 2022, MGI now has the ability to commercialize […]
WALTHAM, MA – Fortis Life Sciences, a strategic platform company providing capital, expertise, and operational resources to grow founder-led life science companies, today announced it is the exclusive channel partner for AccuGenomics in the United States, with co-exclusive rights in Europe. Under the agreement, Fortis will help expand customer access to AccuGenomics’ patented SNAQ™-SEQ Internal […]
Ion Torrent Genexus Dx Integrated Sequencer enables rapid NGS for diagnostic applications and clinical research CARLSBAD, Calif. — Thermo Fisher Scientific today launched the CE-IVD marked Ion Torrent Genexus Dx Integrated Sequencer, an automated, next-generation sequencing (NGS) platform that delivers results in as little as a single day. Designed for use in clinical laboratories, the fully […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
